Urodynamic effects of a vaginal pessary in women with stress urinary incontinence

1983 ◽  
Vol 147 (8) ◽  
pp. 876-884 ◽  
Author(s):  
Narender N. Bhatia ◽  
Arieh Bergman ◽  
John E. Gunning
BMJ Open ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. e040009
Author(s):  
Karina Holm Nissen ◽  
Benjamin C Shayo ◽  
Vibeke Rasch ◽  
Gileard G Masenga ◽  
Ditte Søndergaard Linde

IntroductionPrevious research has shown that vaginal pessaries are a cost-effective treatment for women worldwide suffering from stress urinary incontinence. However, little is known about African women’s experiences with vaginal pessary use. The aim of this study was to understand the experiences of vaginal pessary use among Tanzanian women who had received long-term pessary treatment for stress urinary incontinence.Methods15 semi-structured, individual interviews were conducted over a 2-month period in 2019 with Tanzanian women living in the Kilimanjaro Region who suffered from stress urinary incontinence and who had been using a pessary for at least 18 months. The interview transcripts were analysed using qualitative content analysis.ResultsThe primary motivation for seeking treatment were discomfort from symptoms, social consequences and low quality of life. Perceived benefits from pessary use included improved quality of life with reacquired abilities to perform daily activities, participate in social gatherings, feeling symptom relief and improved sexual relations. Further, some women saw pessary treatment as superior to other locally available treatment options. Perceived barriers for pessary use included shame, husband’s disapproval, limited access to treatment and lack of knowledge among the women as well as healthcare personnel.ConclusionVaginal pessaries are well-perceived as a long-term treatment method among Tanzanian women suffering from stress urinary incontinence. This method may have potential to be implemented large scale in Tanzania if combined with basic health education.


2021 ◽  
Vol 5 (2) ◽  

Introduction: The FemCap is an FDA, and CE mark approved barrier contraceptive device. To our surprise, it was found to apply to several basic unmet reproductive health needs for women. a) The FemCap is time tested hormone-free contraceptive device, b) It offers an alternative delivery system to the traditional vaginal applicator, c) It provides a safe and effective non-surgical treatment for stress urinary incontinence (SUI), d) It enhances the fertility awareness methods. Methodology: We conducted several pilot studies to explore the potential of the FemCap. We compared the retention and distribution of stained vaginal gel if inserted with the FemCap versus the same amount of gel when inserted by the vaginal applicator. We compared the safety and effectiveness of the FemCap with a vaginal pessary that treats stress urinary incontinence. We collected the fertile cervical mucous (Spinnbarkeit) with the FemCap to determine the time of ovulation to enhance the fertility awareness method. Results: The FemCap is a well-established, safe, and effective non-hormonal contraceptive. The retention and distribution of stained vaginal gel inserted with the FemCap is more efficient than the vaginal applicator. The FemCap’s unique storage groove for microbicides can potentially be utilized to treat sexually transmitted infections (STIs) topically. FemCap is also found to be substantially equivalent to the incontinence pessary in controlling stress urinary incontinence (SUI). The FemCap did also help to collect fertile cervical mucous (Spinnbarkeit) when using fertility awareness methods. Conclusion: The multipurpose FemCap would be an ideal tool for nurse practitioners, midwives, and physicians to provide women with safe and effective, hormone-free contraception. It also provides an efficient delivery system for spermicide/microbicides. It is much safer for non-surgical management of stress urinary incontinence. It is useful for the enhancement of fertility awareness methods. It is non-invasive and can be inserted and removed by the woman without professional help.


2007 ◽  
Vol 177 (4S) ◽  
pp. 453-454
Author(s):  
Rachelle L. Prantif ◽  
William C. de Groat ◽  
Donna J. Haworth ◽  
Ronald J. Jankowski ◽  
Michael B. Chancellor ◽  
...  

2006 ◽  
Vol 175 (4S) ◽  
pp. 110-110 ◽  
Author(s):  
Robert D. Moore ◽  
John Miklos ◽  
L. Dean Knoll ◽  
Mary Dupont ◽  
Mickey Karram ◽  
...  

2006 ◽  
Vol 175 (4S) ◽  
pp. 380-380
Author(s):  
Asnat Groutz ◽  
Ronen Gold ◽  
David Pauzner ◽  
Joseph Lessing ◽  
David Gordon

2004 ◽  
Vol 171 (4S) ◽  
pp. 132-132 ◽  
Author(s):  
Peter J. Gilling ◽  
Wilhelm A. Huebner ◽  
Flavio T. Rocha ◽  
Marcus V. Sadi ◽  
Oliver M. Schlarp

2004 ◽  
Vol 171 (4S) ◽  
pp. 249-249
Author(s):  
Paulo Palma ◽  
Cassio Riccetto ◽  
Marcelo Thiel ◽  
Miriam Dambros ◽  
Rogerio Fraga ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document